Browse > Article
http://dx.doi.org/10.5762/KAIS.2010.11.3.1133

Relationship between the Expression of VEGF, HIF-1α, E-cadherin, p53 and Stage in Papillary Thyroid Carcinoma  

Kim, Jong-Sam (Department of Public Health, The Graduate School of Public Health and Welfare Konyang University)
Na, Baeg-Ju (Department of Preventive Medicine, College of Medicine, Konyang University)
Lee, Moo-Sik (Department of Preventive Medicine, College of Medicine, Konyang University)
Kim, Chul-Woung (Department of Preventive Medicine, College of Medicine, Konyang University)
Jeong, Gye-Rim (Department of Public Health, The Graduate School of Konyang University)
Publication Information
Journal of the Korea Academia-Industrial cooperation Society / v.11, no.3, 2010 , pp. 1133-1138 More about this Journal
Abstract
The purpose of our study was to evaluate the correlation between expression of VEGF, HIF-$1{\alpha}$, E-cadherin, and p53 and pathologic stage. We retrospectively reviewed the medical records of the 101 patients who underwent surgery of thyroid nodules from 2000 to 2007. Expression of VEGF, HIF-$1{\alpha}$, E-cadherin, and p53 were examinated immunohistochemically. Papillary thyroid carcinoma in this study included 54 cases of more than 45 years old. Each expression of VEGF, HIF-$1{\alpha}$, E-cadherin, and p53 was analysed. Only expression loss of E-cadherin was associated with the stage. High HIF-1 expression was significantly associated with VEGF immunoreactivity (p<0.05). Expression loss of E-cadherin was independent unfavorable factors. It is suggested that high HIF-$1{\alpha}$ expression may be associated with intratumoral neovascularization possibly through HIF-VEGF pathway.
Keywords
Papillary Thyroid Carcinoma; VEGF; HIF-$1{\alpha}$; E-Cadherin; p53;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Naito A, Iwase H, Kuzushima T, Nakamura T, Kobayashis, " Clinical significance of E-cadherin expression in thyroid neoplasm", Surg Oncol, pp.76(3):176-80, 2001.   DOI
2 Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, et al, "Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features", Am J Pathol, pp. 155:1967-76, 1999.   DOI
3 Yu AY, Frid MG, Shimoda LA, Wiener CM, Stenmark K, Semenza GL, "Temporal, spatial, and oxygen-regulated expression of HIF-1 in the lung", Am J Physiol, pp. 275:L818-26, 1998.
4 Semenza GL, Jiang BH, Leung SW, et al, "Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for HIF- 1", J Biol Chem, pp.271:32529-37, 1996.   DOI
5 Haigh PI, Urbach DR, Rotstein LE "Extent of thyroidectomy is not a major determinant of survival in low-or high-risk papillary thyroid cancer", Ann Surg Oncol, pp. 12:8189, 2005.
6 Park HL, Kwak JY, Kang SS, Kim DY, Kang HG, Shim JY, et al. "The analysis of tumor aggressiveness according to tumor size in occult papillary thyroid carcinoma", J Korean Surg Soc, pp.73:470-75, 2007.   과학기술학회마을
7 Besic N, Pilko G, Petric R, Hocevar M, Zgajnar, "J. Papillary thyroid microcarcinoma: prognostic factors and treatment", J Surg Oncol, pp. 97:221-5, 2008.   DOI
8 Ito T, Seyama T, Mizuno T, et al, "Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland",. Cancer Res, pp. 52:1369-71, 1992.
9 Bilimoria KY, Bentrem DJ, Ko CY, et al. " Extent of surgery affects survival for papillary thyroid cancer", Ann Surg, pp. 246(3):375-384, 2007.   DOI
10 Hedinger C, Williams ED, Sobin LH, "The WHO histological classification of thyroid tumors", a commentary on the second edition Cancer, pp.63:908-11, 1989..
11 Dobashi Y, Sakamoto A, Sugimora H, et al, "Overexpression of p53 as a posiible prognostic factor in human thyroid carcinoma", Am J Surg Pathol, pp. 17:375-81, 1993.   DOI
12 Folkman J, Shing Y, "Angiogenesis" J Biol Chem, pp. 267:10931-4, 1992.
13 Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P, van der Wall E, "Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer", Histopathology, pp. 46:31-6, 2005.   DOI
14 Pignattelli M, Ansari TW, Gunter P, "Loss of membranous E-cadherin expression in pancreatic cancer correlation with lymph node metastasis, high grade, and advanced stage", J Pathol, pp .174:243-48, 1994.   DOI
15 Norrby K, "Angiogenesis: new aspects relating to its initiation and control", APMIS, pp. 105:417-37, 1997.   DOI
16 Tokunga T, Oshika Y, Abe Y, Ozeki Y, Sadshiro S, Kijima H, et al, "Vascular endothelial growth factor mRNA isoform expression pattern is correlate with liver metastases and poor prognosis in colon cancer", Br J Cancer, pp. 77:998-1002, 1998.   DOI
17 Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al, "Vascular permeability factor, an endothelial cell mitogen related to PDG", Science, pp.246:1309-12, 1989.   DOI